Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02279914 · ClinicalTrials.gov registry record · NA
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
A NA study of Abortion, Induced, sponsored by Planned Parenthood of Greater New York.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT02279914 is a NA study of Abortion, Induced that has completed, run by Planned Parenthood of Greater New York. The registered enrollment target is 118 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02279914, a NA study of Abortion, Induced, has completed, sponsored by Planned Parenthood of Greater New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a blinded randomized trial to compare two different doses and intervals of buccal misoprostol for cervical preparation before surgical abortion at 13 to 16 weeks' gestation: 400 mcg administered 3 hours before D\&E (dilation and extraction), and 600 mcg administered 1.5 hours before D\&E. Primary objective: To compare operative times after two different doses and intervals of misoprostol using a non-inferiority design. Secondary objectives: To compare the doses and intervals of misoprostol for differences in: (1) initial cervical dilation; (2) need for mechanical dilation and ease of dilation if required; (3) ability to complete the abortion procedure without further cervical preparation; (4) complications; (5) provider variables including ease of procedure and satisfaction with cervical preparation; (6) patient variables including pre-operative side effects, post-operative pain, and acceptability
Conditions Studied
Interventions
- DRUG Misoprostol 400 mcg 3 hours prior to procedure
- DRUG Misoprostol 600 mcg 90 minutes prior to procedure
Study Locations (1)
New York
- Planned Parenthood of New York City - Margaret Sanger Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02279914
The ClinicalTrials.gov registry entry for NCT02279914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood of Greater New York, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abortion, Induced appearing as the primary indexed condition, and to 2 interventions - of which Misoprostol 400 mcg 3 hours prior to procedure is the first listed.
NCT02279914 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02279914 about?
NCT02279914 is a clinical study titled "Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial". This study is a blinded randomized trial to compare two different doses and intervals of buccal misoprostol for cervical preparation before surgical abortion at 13 to 16 weeks' gestation: 400 mcg administered 3 hours before D\&E (dilation and extraction), and 600 mcg administered 1.5 hours before D\...
What is the current status of trial NCT02279914?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2014-11. Estimated completion is 2016-08.
What conditions does trial NCT02279914 study?
This clinical trial studies the following conditions: Abortion, Induced.
What interventions are being tested in trial NCT02279914?
The interventions under investigation include: Misoprostol 400 mcg 3 hours prior to procedure (DRUG), Misoprostol 600 mcg 90 minutes prior to procedure (DRUG).
Who is sponsoring clinical trial NCT02279914?
This trial is sponsored by Planned Parenthood of Greater New York, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02279914 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abortion, Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.